Osteoid osteoma is a benign bone-forming tumor with hallmark of tumor cells directly forming mature bone. Osteoid osteoma accounts for around 5% of all bone tumors and 11% of benign bone tumors with a male predilection. It occurs predominantly in long bones of the appendicular skeleton. According to Musculoskeletal Tumor Society staging system for benign tumors, osteoid osteoma is a stage-2 lesion. It is classified based on location as cortical, cancellous, or subperiosteal. Nocturnal pain is the most common symptom that usually responds to salicyclates and non-steroidal anti-inflammatory medications. CT is the modality of choice not only for diagnosis but also for specifying location of the lesion, i.e. cortical vs sub periosteal or medullary. Non-operative treatment can be considered as an option since the natural history of osteoid osteoma is that of spontaneous healing. Surgical treatment is an option for patients with severe pain and those not responding to NSAIDs. Available surgical procedures include radiofrequency (RF) ablation, CT-guided percutaneous excision and en bloc resection.
Introduction
Osteoid osteoma is a benign bone-forming tumor with hallmark of tumor cells directly forming mature bone. 1 These are small, distinctive, nonprogressive, benign osteoblastic lesions. Bergstrand first described osteoid osteoma in 1930 and Jaffe in 1935 characterized it as a benign osteoblastic tumor.
2,3

Epidemiology
Osteoid osteoma accounts for around 5% of all bone tumors and 11% of benign bone tumors. 4 Osteoid osteoma is the third most common biopsy analyzed benign bone tumor after osteochondroma and nonossifying fibroma. Two to 3% of excised primary bone tumors are osteoid osteomas. 5 Males are more commonly affected with an approximate male/female ratio of 2 to 1. 5 Adolescents and young adults are usually affected in the second decade of life, with most patients being under the age of 20 years. It is less likely to be seen in patients under 5 years of age or in adults greater than 40 years. 4 
Localisation
Osteoid osteoma occurs predominantly in the appendicular skeleton. Spine is involved in one tenth of the cases. 6 Flat bones with intramembraneous formation in the body and skull are rarely affected. The lower extremity is more commonly affected than the upper extremity as shown in Figure  1 . Commonly long bones particularly the femur and tibia are involved, followed far behind by bones of the feet, with a predilection for the talar neck. Common sites of femoral involvement are the juxta-or intraarticular regions of the femoral neck. In the upper extremity, phalanges of the hand are commonly affected. 4 
Classification
In long bones, osteoid osteoma is more often situated in the cortico-diaphyseal or metaphyseal regions, but other localizations such as intramedullary, subperiosteal, epiphyseal or apophyseal have also been noted. 6 It is very rare to have two osteoid osteomas in the same patient. 4 According to Musculoskeletal Tumor Society staging system for benign tumors, osteoid osteoma is a stage-2 lesion. It is classified as cortical, cancellous, or subperiosteal. Cortical lesions are most common. 4 
Clinical presentation
Pain is the most common symptom. Usually it is a dull ache, which is unremitting and starts off as mild and intermittent that gradually increases in intensity and persistence. The pain has a tendency to become increasingly severe at night and usually responds to salicyclates and non-steroidal anti-inflammatory medications. If osteoid osteoma involves a bone in a subcutaneous location, then the patient usually presents with swelling, erythema and tenderness.
If the proximal femur or pelvis is involved, the patient can present with referred pain in the knee. Lesions that are within the joint or juxta-articular can present with synovitis. If this continues to progress, the patient can present with joint pain, flexion contracture, decreased range of motion, and a limp or antalgic gait. Sometimes in children, a limp may be the only presenting symptom. If the lesion involves the open physis, it can result in limb length discrepancy with potential coronal and/or sagittal malalignment.
Referred pain and muscle atrophy can result in misdiagnosis of a neurological disorder commonly seen in axial skeleton involvement with postural scoliosis due to paravertebral muscle spasm, which is reversible after treatment. 7 
Pathogenesis
The exact pathogenesis of osteoid osteoma remains unknown. High levels of prostaglandin E2 and prostacyclin have been found within the nidus that is believed [Orthopedic Reviews 2018; 10:7496]
[page 109] to cause local inflammation and vasodilatation. A study by Mungo et al. 8 revealed increased levels of cyclooxygenase-2 expression in nidus osteoblasts. Cyclooxygenase-2 inhibition is believed to be a mechanism by which NSAIDs provide symptomatic relief in osteoid osteomas. These inflammatory mediators may also contribute to perilesional sclerosis exhibited by most osteoid osteomas. In addition, high concentrations of intralesional unmyelinated nerve fibers have been implicated in the pathogenesis of the exquisite nocturnal pain. These processes probably function in parallel to produce the characteristic inflammatory symptoms. 9, 10 Historically, there has been debate over the years about the precise nature of osteoid osteomas. Initially considered a neoplasm by Jaffe, other investigators proposed a reactive or reparative process citing its limited growth potential and its ability to spontaneously regress in some cases. 2 Currently, most pathologists agree about the neoplastic nature of osteoid osteomas. The tumour's histological similarity to osteoblastoma supports the belief that it is a benign tumour derived from the osteoblasts. There have been few cytogenetic studies that reported clonal cytogenetic abnormalities, including alterations involving chromosome 22q, a region which contains genes involved in cell proliferation that is commonly affected in a variety of other neoplasms. 11 
Gross features
When removed intact, osteoid osteomas are usually small, and round to oval in shape. The cut surface is red to pink when fresh, and brown to granular after formalin fixation. They are well demarcated from the surrounding white sclerotic cortical bone. The nidus color is related to vascularity of intertrabecular areas. As osteoid osteomas are now treated by radiofrequency ablation, such intact specimens as described above are rarely received for histopathology. 12 
Microscopic features
Histologically, the nidus is well circumscribed and composed of haphazardly interanastomosing trabeculae of variably mineralized woven bone. The trabeculae are usually thin and short, but can be sclerotic and broad and are rimmed by a single layer of osteoblasts. Scattered osteoclasts are also present on the surface of bony trabeculae ( Figure 2 ). The osteoblasts are plump, uniform in size and shape and have eccentric nuclei with small nucleoli and open chromatin. Cytoplasm is usually amphophilic. No nuclear pleomorphism or increased mitotic activity is seen. The intertrabecular stroma is loose and fibrovascular ( Figure 3 ). The reactive bone surrounding the nidus is dense cortical or trabecular bone and when the tumor grows closer to the bone surface, it becomes more pronounced. In medullary lesions, it is less pronounced. 13 The pathologic evaluation of osteoid [ 
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Immunohistochemical features
S100 and neurofilament show nerve fibers involving tumor. 15 Osteoid osteomas also show strong nuclear expression for Runx2 and Osterix, which are regulatory transcription factors. This suggests that osteoid osteomas share common genetic pathways with normal skeletal development. 16 
Differential diagnosis
Osteoid osteoma can be distinguished from other bone forming tumors based on the difference in size, location, pathology, and clinical symptoms. 17 A small Brodie abscess with a radiolucent center and surrounding reactive sclerosis can mimic osteoid osteoma. With intracortical Brodie abscess the sequestrum is irregular in shape and the inner margin of the lucency is not smooth, whereas in osteoid osteoma, the inner margins are usually smooth. 18, 19 Tumors can also mimic osteoid osteomas. Chondroblastomas in epiphyseal locations of children with osteolytic lesions and extensive bone marrow edema and periosteal reaction can resemble osteoid osteoma. However the epiphyseal and intramedullary location is more characteristic for chondroblastomas, whereas osteoid osteomas are usually diaphyseal and intracortical. In the pediatric age group cortical lesions in the tibia caused by osteofibrous dysplasia, adamantinoma and stress fractures produce cortical thickening and proliferation that can be mistaken for osteoid osteomas. In stress fractures, the reactive woven bone network is well oriented around trabeculae of fractured bone. It is not haphazard and lacks the small irregular trabeculae seen in osteoid osteomas. Other lesions such as nonossifying fibromas, enchondromas, eosinophilic granulomas, Perthes disease, tuberculosis, neuromuscular conditions and malignant bone tumors can also be considered. In addition to clinical features, imaging techniques such as CT, bone and SPECT scans can assist in diagnosing the lesion.
Imaging findings Plain radiography
Osteoid osteoma appears as an oval lytic lesion located within dense cortical bone in the diaphysis surrounded by fusiform cortical bone thickening and sclerosis. The cortical based lucency is less than 2 cm. 20 Underlying lytic nidus may not always be visualized due to significant sclerosis. The sclerotic reactive bone often is seen distant from the lesion, in extra capsular location.
The tumor present at subperiosteal location is a rounded sclerotic focus that elevates the periosteum with limited sclerotic reaction. In intramedullary location, these tumors are well-circumscribed with a complete or partially calcified nidus. The surrounding reactive sclerosis can be minimal or absent ( Figure 4A ). In posterior elements of the spine, osteoid osteomas are difficult to localize. The nidus is not visualized on plain films but additional findings such as scoliosis with concavity at the side of the lesion is seen in these cases. 6, 21 A study done by PARK et al showed 28.6% of osteoid osteoma cases in their study had no plain radiography abnormality despite very typical clinical presentations. Radionuclide imaging was used to diagnose these cases. Therefore in cases where plain radiographs are not conclusive but clinical suspicion is high, further imaging workup should be requested.
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CT
CT is the modality of choice for diagnosis and specifying location of lesion, i.e. cortical vs sub periosteal or medullary. CT shows well-defined nidus as round or oval with low attenuation ( Figure 5 ). Nidus can show mineralization which may be punctate, amorphous or ring like. Surrounding reactive sclerosis can vary from mild sclerosis to extensive periosteal reaction and new bone formation, which may obscure the nidus. duration and may be a marker of tumor age (P=0.007, hazard ratio=0.193). They however reported no association of nidus size with pain duration (P=0.092). In their study, diaphyseal osteoid osteomas displayed a lower ratio of nidus mineralization as compared to those in epiphyseal and metaphyseal locations. 23 Dynamic contrast-enhanced CT helps in differentiating osteoid osteoma from bone cysts and chronic osteomyelitis, specifically Brodie abscess which are avascular. In these cases the tumor nidus shows rapid early arterial enhancement and appears hypervascular. [24] [25] [26] Spinal osteoid osteoma is better characterized by CT. The nidus is visible as lowdensity area in posterior elements. Surrounding sclerosis of the ipsilateral pedicle, lamina, or transverse process may be present.
Bone scintigraphy
Technetium-99-labeled bone scintigraphy has high sensitivity for confirming diagnosis of osteoid osteoma. The sensitivity of skeletal scintigraphy for detection is 100%. 27 On bone scan characteristic feature is very intense, round activity at nidus surrounded by less intensity of reactive bone. This is known as double density sign. 28 The increased intensity of nidus is because of increased bone turn over. The less intense peripheral radiotracer uptake, represents the host bone tumor response (Figure 4) The sign is infrequently seen with spinal osteoid osteoma because of less peripheral sclerosis in vertebral bodies. 29 A study done by PARK et al found out that all the patients in their study with or without conclusive appearance on plain radiography, were correctly identified on bone scintigraphy. They recommended that if the radionuclide imaging is positive, CT scans should be next imaging modality for further evaluation but in cases where radionuclide imaging is negative, MRI should be done for the diagnosis of other underlying bone pathologies. 22 
PET
PET may have role in initial diagnosis and post treatment follow-up. A study previously reported that tumor nidus exhibits 18FFDG-avid glucose metabolism, whereas the surrounding sclerosis does not. In follow up cases of radiofrequency ablation (RFA), hypermetabolic activity is absent. Some authors suggested role of PET specifically in cases of spinal osteoid osteoma. But this modality requires more research work to be done to prove its utility in diagnosis and follow up. [30] [31] [32] [33] In addition to FDGPET/CT, 68Ga-PSMA PET/CT, which is used in prostate cancer staging and restaging, has been used to detecta case of osteoid osteoma. This uptake was likely because of osteoblastic activity in osteoid osteoma but needs further evaluation to investigate its specific role and accuracy in diagnosis of osteoid osteoma. 34, 35 MRI MRI is more sensitive than CT scan for detection of reactive changes in soft tissue. MRI is a reliable method of visualizing the nidus. The MRI appearance of nidus depends on its location in the cortex. The closer the lesion is to the medullary zone, the greater the role of MRI in recognizing the nidus compared to CT scan. However, compared to MRI, CT scan is more specific for identifying a nidus. 36, 37 The appearance of nidus on MRI is variable depending on mineralization and its vascularity. Nidus on MR T1 weighted sequence appears as round lesion, slightly hyper intense to intermediate signals to adjacent muscle and hyper intense to heterogeneous signals on T2 weighted and STIR sequences ( Figure 4B and C). Nidus can be hypointense in all sequences, depending on vascularity and mineralization. Tumor enhancement is variable, can be diffuse or heterogeneous ( Figure 4C ). The surrounding osteosclerosis appears as low signal on both T1-and T2-weighted sequences. 38, 39 There is high potential of misdiagnosing osteoid osteoma as neoplastic lesion or oversight it when other modalities are not used for diagnosis. Small lesions may be hard to isolate on MRI as nidus signal is frequently similar to that of surrounding cortex. 38 Although CT is the modality of choice in diagnosis of osteoid osteoma, but in patients with atypical clinical presentations, in whom the pain does not respond to NSAIDs and where no obvious abnormality on plain roentgenograms is reported, MRI is done to investigate the underlying cause. MRI is more sensitive than CT scan for detection of reactive changes in soft tissue and surrounding bone edema. Klontzas et al. reported that the half-moon sign of bone marrow edema was associated with the presence of osteoid osteoma in femoral neck. The half-moon sign is highly specific and sensitive for presence of osteoid osteoma in the femoral neck with 94.7% specificity and 100% sensitivity and positive and negative predictive values of 91.7% and 100%, respectively (D). But some authors have questioned this high specificity as the half-moon sign of bone marrow edema in femoral neck can be seen in intermediate-grade stress fractures of the femoral neck on MRI. It has therefore been recommended that if clinical features are suggestive of osteoid osteoma, then CT should be performed to determine the presence of a potentially occult nidus on MRI.
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Pitfall of imaging
The diagnosis of osteoid osteoma on imaging can be challenging in cases where there are severe associated inflammatory changes such as a prominent periosteal reaction, exaggerated synovial hypertrophy, joint effusion, extensive bone marrow and soft tissue edema. In cases of significant associated periosteal reaction and soft tissue edema in a young patient, the differential diagnoses of osteomyelitis or malignant bone tumor, such as Ewing sarcoma have to be considered. A small nidus obscured by extensive bone marrow and soft-tissue edema needs to be differentiated from traumatic injury or infection. For accurate and correct radiological diagnosis it is mandatory to identify the nidus. 
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Treatment
Non-operative
Non-operative treatment can be considered as an option since the natural history of osteoid osteoma is that of spontaneous healing. 40 Moberg 40 and Golding 41 reported resolution of symptoms with conservative management in osteoid osteoma within 6 to 15 years. Use of aspirin or other nonsteroidal anti-inflammatory medications (NSAIDs) decreases this time to 2 to 3 years. 42, 43 Use of this nonoperative treatment option risks the potential side effects of protracted NSAID treatment. In anatomical areas where osteoid osteoma is not easily accessible surgically, this may be a viable treatment option. However caution should be exercised with this option, as there are some reports that these tumors progress to osteoblastoma with prolonged NSAID treatment. 44 
Surgical management
Surgical treatment is an option for patients with severe pain and those not responding to NSAIDs. This option should also be considered for those patients not willing to tolerate pain and those at particular risk of long-term renal and gastrointestinal complications of NSAIDs. Moreover in children with open physes, continued presence of these tumors can lead to growth disturbances like limb length discrepancies, scoliosis and osteoarthritis. 45 Available procedures include CT-guided radiofrequency (RF) ablation, en bloc resection, and CTguided percutaneous excision.
En bloc resection
For symptomatic relief, the entire nidus has to be excised. Complete removal of the sclerotic reactive bone however, is not required. Preoperative roentgenograms and CT scans delineate the location of the nidus. This resection has the drawback of an open surgical approach with excision of sclerotic bone leaving behind a bone defect which may require bone grafting and internal fixation with consequent restrictions on postoperative activities and weight bearing. With this approach, intraoperative localization of the tumor may be challenging leading to partial removal and potential recurrence. For structurally critical anatomical sites like the femoral neck, one can consider deroofing and curettage. For intra-articular locations of the tumor, arthroscopic excision is a possible option. 46 
CT guided percutaneous techniques
Over the years, to reduce the surgical morbidity of open procedures, several percutaneous techniques using CT guidance have been used. These include trephine excision, cryoablation, radiofrequency ablation and laser thermocoagulation. [47] [48] [49] [50] [51] Fine drills, bone trephine, Tru-Cut needles, and cannulated curettes have been used with percutaneous CT guided techniques performed in the outpatient setting. Using percutaneous CT guided resection, Sans and colleagues 52 showed a cure rate of 84% at 3.7 years with two complications of femoral fractures at 2 months. For osteoid osteomas of the hip Muscolo and colleagues 53 showed superior results of percutaneous resection guided by CT.
Roqueplan and colleagues 54 reported percutaneous CT guided trephine resection success rate of 95% at 2 years. Two patients got skin burns and one had meralgia. The same authors reported 94% success rate with interstitial laser ablation at 2 years and complications of infection, tendonitis, hematoma, and common peroneal nerve injury.
Percutaneous thermocoagulation of osteoid osteoma was reported by de Berg and colleagues 55 successfully in 17 patients. Hoffman et al. 56 reported 5-year results of radiofrequency ablation with confirmed cure in 38 of 39 patients. Complications in this series included one broken drill and one case of infection. Papathanassiou et al. 57 in their series of 21 patients over 5 years reported a primary cure rate of 89.6% that increased to 93% if a second treatment was required. Rosenthal and colleagues 58 reported their results of CT guided RF ablation in 263 patients. A total of 271 procedures were performed of which 249 were for initial tumor treatment, 14 for recurrence after open excision, and 8 for recurrence after prior RF ablation. They reported 2 minor complications and recommended RF ablation as the treatment of choice with 91% clinical success, brief recovery and low complication rate.
It is important to note that irrespective of the technique used, a biopsy is required to confirm the diagnosis. In order to evaluate complete removal of the nidus, several techniques have been used which include roentgenograms, CT scans, and microradiography of specimens. Table l 59-118 is a synopsis of the published literature referencing all case series with more than 15 patients listing the treatment and outcomes.
Conclusions
Osteoid osteoma is a distinct benign bone-producing tumor. Nonoperative treatment with NSAIDs is an appropriate option for pain control. Surgical options should be considered when conservative treatment fails or is not indicated for or not opted for by the patient. Minimally invasive methods including CT-guided excision and RF ablation have shown promise with highly successful outcomes.
